Study design
kidney disease
KIDNEY DISEASE
This study was designed as a 16-week randomized-controlled pilot trial in which 45 patients on HD with kidney disease quality of life (KDQOL) scores below 50 were randomized 1:1 to the intervention vs. control. Written informed consent was obtained from all subjects.Randomization procedures were performed through REDCap The study team, including the social workers that delivered the intervention, was aware of the randomization allocation but the patient’s treatment team and study subjects were not explicitly made aware. Subjects from both groups continued to receive medical care from their treating health care providers.